Search Results - "Pedrazzoli, P."

Development of adaptive immune effector therapies in solid tumors by Comoli, P., Chabannon, C., Koehl, U., Lanza, F., Urbano-Ispizua, A., Hudecek, M., Ruggeri, A., Secondino, S., Bonini, C., Pedrazzoli, P.

“…State-of-the-art treatment strategies have drastically ameliorated the outcome of patients affected by cancer. However, resistant and recurrent solid tumors…”
Get full text

Humoral and cellular response before and after the fourth BNT162b2 vaccine dose in patients with solid tumors on active treatment by Lasagna, A., Bergami, F., Lilleri, D., Percivalle, E., Quaccini, M., Comolli, G., Sarasini, A., Sammartino, J.C., Ferrari, A., Arena, F., Cicognini, D., Schiavo, R., Lo Cascio, G., Baldanti, F., Pedrazzoli, P., Cassaniti, I.

Get full text

Treatment Following Progression in Metastatic Melanoma: the State of the Art from Scientific Literature to Clinical Need by Serra, F., Barruscotti, S., Dominioni, T., Zuccarini, A., Pedrazzoli, P., Chiellino, S.

“…Introduction In the last few years, the advent of targeted therapy and immunotherapy has improved the management and the prognosis of metastatic melanoma, but…”
Get full text

Is allogeneic transplant for solid tumors still alive? by Bregni, M, Badoglio, M, Pedrazzoli, P, Lanza, F

Get full text

Is it time to optimize immunonutrition in cancer patients according to muscle mass? by Casirati, A., Da Prat, V., Cereda, E., Sebastiani, F., Trestini, I., Perrone, L., Serra, F., Cintoni, M., Pedrazzoli, P., Caccialanza, R.

Get full text

International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer by Novello, S., Torri, V., Grohe, C., Kurz, S., Serke, M., Wehler, T., Meyer, A., Ladage, D., Geissler, M., Colantonio, I., Cauchi, C., Stoelben, E., Ceribelli, A., Kropf-Sanchen, C., Valmadre, G., Borra, G., Schena, M., Morabito, A., Santo, A., Gregorc, V., Chiari, R., Reck, M., Schmid-Bindert, G., Folprecht, G., Griesinger, F., Follador, A., Pedrazzoli, P., Bearz, A., Caffo, O., Dickgreber, N.J., Irtelli, L., Wiest, G., Monica, V., Porcu, L., Manegold, C., Scagliotti, G.V.

“…Several strategies have been investigated to improve the 4% survival advantage of adjuvant chemotherapy in early-stage non-small-cell lung cancer (NSCLC). In…”
Get full text

Current use of clinical nutrition in oncology patients: Real world evidence from big data in Italy by Di Costanzo, F., Caccialanza, R., Santoro, A., Gavazzi, C., Pedrazzoli, P.

Get full text

Update of the recommendations of the Italian Society of Medical Oncology on vaccination for seasonal influenza and pneumococcal infection in patients with cancer: Focus on prevention of pneumonia by Pedrazzoli, P., Piralla, A., Valentino, F., Cinieri, S., Baldanti, F.

Get full text

The evolving landscape of human papillomavirus-related oropharyngeal squamous cell carcinoma at a single institution in Northern Italy by Morbini, P, Alberizzi, P, Ferrario, G, Capello, G, De Silvestri, A, Pedrazzoli, P, Tinelli, C, Benazzo, M

“…The increasing incidence of HPV-related oropharyngeal squamous cell carcinoma (OPSCC) observed in several developed countries has not yet been documented in…”
Get full text

Vaccination for seasonal influenza in patients with cancer: recommendations of the Italian Society of Medical Oncology (AIOM) by Pedrazzoli, P., Baldanti, F., Donatelli, I., Castrucci, M.R., Puglisi, F., Silvestris, N., Cinieri, S.

“…Influenza virus causes annual epidemics in the winter–spring season with significant morbidity in the general population and important mortality in high-risk…”
Get full text

Corrigendum to “International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer”: [Annals of Oncology 33 (2022) 57-66] by Novello, S., Torri, V., Grohe, C., Kurz, S., Serke, M., Wehler, T., Meyer, A., Ladage, D., Geissler, M., Colantonio, I., Cauchi, C., Stoelben, E., Ceribelli, A., Kropf-Sanchen, C., Valmadre, G., Borra, G., Schena, M., Morabito, A., Santo, A., Gregorc, V., Chiari, R., Reck, M., Schmid-Bindert, G., Folprecht, G., Griesinger, F., Follador, A., Pedrazzoli, P., Bearz, A., Caffo, O., Dickgreber, N.J., Irtelli, L., Wiest, G., Monica, V., Porcu, L., Manegold, C., Scagliotti, G.V.

Get full text

Multimodal Approach of Pulmonary Artery Intimal Sarcoma: A Single-Institution Experience by Dore, R., Paulli, M., Pedrazzoli, Paolo, D'Armini, Andrea Maria, Callegari, M. G., Klersy, Catherine, Sciortino, A., Pagani, A., Pin, M., Valentino, F., Grazioli, V., Secondino, S., Morbini, Patrizia

“…Introduction. Pulmonary artery sarcoma (PAS) is a rare tumor, whose therapeutic approach is mainly based on surgery, either pneumonectomy or pulmonary…”
Get full text

Vaccination for herpes zoster in patients with solid tumors: a position paper on the behalf of the Associazione Italiana di Oncologia Medica (AIOM) by Pedrazzoli, P., Lasagna, A., Cassaniti, I., Ferrari, A., Bergami, F., Silvestris, N., Sapuppo, E., Di Maio, M., Cinieri, S., Baldanti, F.

“…Herpes zoster (HZ) is the infectious reactivation of the varicella-zoster virus. HZ is more frequent in immunocompromised subjects, including patients with…”
Get full text

A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort study by Lasagna, A., Agustoni, F., Percivalle, E., Borgetto, S., Paulet, A., Comolli, G., Sarasini, A., Bergami, F., Sammartino, J.C., Ferrari, A., Zavaglio, F., Arena, F., Lilleri, D., Secondino, S., Falzoni, M., Schiavo, R., Klersy, C., Lo Cascio, G., Cavanna, L., Baldanti, F., Pedrazzoli, P., Cassaniti, I.

“…Very few cancer patients were enrolled in coronavirus disease-2019 vaccine studies. In order to address this gap of knowledge, real-world studies are…”
Get full text

Vaccination for seasonal influenza, pneumococcal infection and SARS-CoV-2 in patients with solid tumors: recommendations of the Associazione Italiana di Oncologia Medica (AIOM) by Pedrazzoli, P., Lasagna, A., Cassaniti, I., Piralla, A., Squeri, A., Bruno, R., Sacchi, P., Baldanti, F., Di Maio, M., Beretta, G.D., Cinieri, S., Silvestris, N.

“…Patients with cancer have a well-known and higher risk of vaccine-preventable diseases (VPDs). VPDs may cause severe complications in this setting due to…”
Get full text

T-cell therapy for EBV-associated nasopharyngeal carcinoma: preparative lymphodepleting chemotherapy does not improve clinical results by Secondino, S., Zecca, M., Licitra, L., Gurrado, A., Schiavetto, I., Bossi, P., Locati, L., Schiavo, R., Basso, S., Baldanti, F., Maccario, R., Locatelli, F., Siena, S., Pedrazzoli, P., Comoli, P.

“…We and others have demonstrated that adoptive cell therapy with Epstein–Barr virus (EBV)-specific autologous cytotoxic T lymphocytes (CTLs) may control disease…”
Get full text

Long lasting responses to adoptive T-cell therapy in relapsed EBV-related nasopharyngeal carcinoma by Secondino, S., Bossi, P., Gurrado, A., Basso, S., Imarisio, I., Pagani, A., Zecca, M., Pisani, I., Bagnarino, J., Casanova, M., Bergamini, C., Perotti, C., Licitra, L.F., Comoli, P., Pedrazzoli, P.

Get full text

Immunogenicity and safety after the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors on active treatment: a prospective cohort study by Lasagna, A., Bergami, F., Lilleri, D., Percivalle, E., Quaccini, M., Alessio, N., Comolli, G., Sarasini, A., Sammartino, J.C., Ferrari, A., Arena, F., Secondino, S., Cicognini, D., Schiavo, R., Lo Cascio, G., Cavanna, L., Baldanti, F., Pedrazzoli, P., Cassaniti, I.

“…Although a full course of coronavirus disease 2019 (COVID-19) vaccine is effective in cancer patients, the duration of the protection and the efficacy of a…”
Get full text

Intensified chemotherapy with stem-cell rescue in germ-cell tumors by Simonelli, M., Rosti, G., Banna, G.L., Pedrazzoli, P.

“…Based on the high chemosensitivity of germ-cell tumors (GCTs), the concept of high-dose chemotherapy (HDCT) has been developed worldwide and investigated…”
Get full text

Six-month humoral and cellular immune response to the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors: a longitudinal cohort study with a focus on the variants of concern by Lasagna, A., Bergami, F., Lilleri, D., Percivalle, E., Quaccini, M., Serra, F., Comolli, G., Sarasini, A., Sammartino, J.C., Ferrari, A., Arena, F., Secondino, S., Cicognini, D., Schiavo, R., Lo Cascio, G., Cavanna, L., Baldanti, F., Pedrazzoli, P., Cassaniti, I.

“…The role and the durability of the immunogenicity of the third dose of vaccine against COVID-19 variants of concern in cancer patients have to be elucidated…”
Get full text